EUVIMEDEUVIMED entdecken
Open Access

Synthesis and Characterization of Transferrin and Cell-Penetrating Peptide-Functionalized Liposomal Nanoparticles to Deliver Plasmid ApoE2 In Vitro and In Vivo in Mice

Chinenye Edith Muolokwu, Avinash Gothwal, Takahisa Kanekiyo, Jagdish Singh iD

Molecular Pharmaceutics · 2025

DOI: 10.1021/acs.molpharmaceut.4c00870 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Chinenye Edith Muolokwu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, School of Pharmacy, College of Health and Human Sciences, North Dakota State University, Fargo, North Dakota 5…. Hauptthemen laut MEDLINE: Liposomes, Transferrin, Nanoparticles, Apolipoprotein E2. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is a prevalent neurodegenerative condition characterized by the aggregation of amyloid-β plaques and neurofibrillary tangles in the brain, leading to synaptic dysfunction and neuronal degeneration. Recently, new treatment approaches involving drugs such as donanemab and lecanemab have been introduced for AD. However, these drug regimens have been associated with adverse effects, leading to the exploration of gene therapy as a potential treatment option. The apolipoprotein E (ApoE) isoforms (ApoE2, ApoE3, and ApoE4) play pivotal roles in AD pathology, with ApoE2 known for its protective effects against AD, making it a promising candidate for gene therapy interventions. However, delivering therapeutics across the blood-brain barrier (BBB) remains a crucial challenge in treating neurological disorders. Liposomes, lipid-based vesicles, are effective nanocarriers due to their ability to shield therapeutics from degradation, though they often lack specificity for brain delivery. To address this issue, liposomes were functionalized with cell-penetrating peptides such as penetratin (Pen), cingulin (Cgn), and a targeting ligand transferrin (Tf). This modification strategy aimed to enhance the delivery of therapeutic ApoE2 plasmids across the BBB to neurons, thereby increasing the level of ApoE2 protein expression. Experimental findings demonstrated that dual-functionalized liposomes (CgnTf and PenTf) exhibited higher cellular uptake, biodistribution, and transfection efficiency than single-functionalized (Pen, Cgn, or Tf) and nonfunctionalized liposomes. In vitro studies using primary neuronal cells, bEnd.3 cells, and primary astrocytes consistently supported these findings. Following a single dose treatment via tail vein administration in C57BL6/J mice, in vivo biodistribution results showed significantly higher biodistribution levels in the brain (∼12% ID/gram of tissue) for dual-functionalized liposomes. Notably, treatment with dual-functionalized liposomes resulted in a 2-fold increase in ApoE2 expression levels compared to baseline levels. These findings highlight the potential of dual-functionalized liposomes as an efficacious delivery system for ApoE2 gene therapy in AD, highlighting a promising strategy to address the disease's underlying mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiposomesTransferrinNanoparticlesApolipoprotein E2Cell-Penetrating PeptidesBlood-Brain BarrierPlasmidsAnimalsMiceAlzheimer DiseaseBrainMice, Inbred C57BLHumans

Stichwörter der Autor:innen

Alzheimer’s diseaseApoE2cell-penetrating peptidesgene therapyliposomestargeting ligand

Substanzen

LiposomesTransferrinApolipoprotein E2Cell-Penetrating Peptides

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, School of Pharmacy, College of Health and Human Sciences, North Dakota State University, Fargo, North Dakota 58108-6050, United States.
  • Department of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224, United States.

ORCID-Profile: Jagdish Singh

Förderung

  • NIA NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Muolokwu, C. E., Gothwal, A., Kanekiyo, T., & Singh, J. (2025). Synthesis and Characterization of Transferrin and Cell-Penetrating Peptide-Functionalized Liposomal Nanoparticles to Deliver Plasmid ApoE2 In Vitro and In Vivo in Mice. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00870

Vancouver

Muolokwu CE, Gothwal A, Kanekiyo T, Singh J. Synthesis and Characterization of Transferrin and Cell-Penetrating Peptide-Functionalized Liposomal Nanoparticles to Deliver Plasmid ApoE2 In Vitro and In Vivo in Mice. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.4c00870

BibTeX
@article{Muolokwu2025,
  author = {Muolokwu, Chinenye Edith and Gothwal, Avinash and Kanekiyo, Takahisa and Singh, Jagdish},
  title = {Synthesis and Characterization of Transferrin and Cell-Penetrating Peptide-Functionalized Liposomal Nanoparticles to Deliver Plasmid ApoE2 In Vitro and In Vivo in Mice},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  doi = {10.1021/acs.molpharmaceut.4c00870}
}
Kostenlos starten →